Human LGALS9C knockout A549 cell line
Be the first to review this product! Submit a review
|
(0 Publication)
- Sanger seq
Unknown
Sanger Sequencing - Human LGALS9C knockout A549 cell line (AB267189)
Allele-1 : 22 bp deletion in exon3
- Sanger seq
Unknown
Sanger Sequencing - Human LGALS9C knockout A549 cell line (AB267189)
Allele-3 : 4 bp deletion in exon 3.
- Sanger seq
Unknown
Sanger Sequencing - Human LGALS9C knockout A549 cell line (AB267189)
Allele-2 : 8 bp deletion in exon 3.
Complementary Products
Product details
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Handling procedures
Initial handling guidelines
Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.
1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.
Subculture guidelines
- All seeding densities should be based on cell counts gained by established methods.
- A guide seeding density of 2x104 cells/cm2 is recommended.
- Cells should be passaged when they have achieved 80-90% confluence.
- Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium
F-12K + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LGALS9C influences immune response modulation highlighting its presence in immune cell function. It interacts with biologically significant partners often forming a complex with receptors like Tim-3 on T cells. This interaction can either promote cell death in certain contexts or drive anti-inflammatory responses. The involvement of LGALS9C in regulating the survival and function of these cells underlines its importance in maintaining homeostasis within the immune system.
Pathways
LGALS9C plays significant roles within immune signaling pathways including the Tim-3/Galectin-9 pathway. It also intersects with the apoptosis regulatory pathway influencing cellular outcomes during immune responses. LGALS9C interacts with proteins such as Tim-3 and PD-1 which share pathways that regulate immune responses and tolerance. The modulation of immune checkpoints places LGALS9C within a network of pathways that could influence therapy in chronic inflammation and cancer.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com